| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |